Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2025-12-25 @ 10:05 PM
Study NCT ID:
NCT01696058
Status:
COMPLETED
Last Update Posted:
2014-11-25
First Post:
2012-09-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-26
First Submit QC Date:
None
Study First Post Date:
2012-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-09-05
Results First Submit QC Date:
None
Results First Post Date:
2014-11-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-13
Last Update Post Date:
2014-11-25
Last Update Post Date Type:
ESTIMATED